The effect of emicizumab regimen on haemophilia outcomes
Lancet Haematol
.
2019 Jun;6(6):e286-e287.
doi: 10.1016/S2352-3026(19)30070-5.
Epub 2019 Apr 16.
Author
Margaret V Ragni
1
Affiliation
1
University of Pittsburgh Medical Center, Pittsburgh, PA, USA; Hemophilia Center of Western Pennsylvania, Pittsburgh PA 15213-4306, USA. Electronic address: ragni@pitt.edu.
PMID:
31003964
DOI:
10.1016/S2352-3026(19)30070-5
No abstract available
Publication types
Comment
MeSH terms
Antibodies, Bispecific*
Antibodies, Monoclonal, Humanized
Hemophilia A*
Humans
Substances
Antibodies, Bispecific
Antibodies, Monoclonal, Humanized
emicizumab
Associated data
ClinicalTrials.gov/NCT02196207